(Q63832018)
Statements
Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif®) in MS Patients. Case Series for Adjustment of Treatment Strategy and Its Monitoring (English)
0 references
May 2005
0 references
June 2008
0 references
231
0 references